Traci Mansfield - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Traci Mansfield

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Pharmacogenomics|August 8, 2002

CuraGen CorporationTraci Mansfield, Mark R Vincent

Journal of Diabetes|November 22, 2015

Efficacy and safety of dapagliflozin in Asian patients with type 2 diabetes after metformin failure: A randomized controlled trialWenying Yang, Ping Han, Kyung-Wan Min, et al.

Diabetes Technology & Therapeutics|September 18, 2018

Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled TrialRobert R Henry, Poul Strange, Rong Zhou, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Pharmacogenomics|August 8, 2002

CuraGen CorporationTraci Mansfield, Mark R Vincent

Journal of Diabetes|November 22, 2015

Efficacy and safety of dapagliflozin in Asian patients with type 2 diabetes after metformin failure: A randomized controlled trialWenying Yang, Ping Han, Kyung-Wan Min, et al.

Diabetes Technology & Therapeutics|September 18, 2018

Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled TrialRobert R Henry, Poul Strange, Rong Zhou, et al.

Pageof 1